Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01300052 · ClinicalTrials.gov registry record · Phase 2
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT01300052 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 68 participants.
The verdict
NCT01300052, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether AN2728 topical ointment is a safe and effective treatment for mild-to-moderate plaque-type psoriasis.
Interventions
- DRUG AN2728 ointment, 2%
- DRUG Ointment Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-01-26 |
| Est. Completion | 2011-06-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01300052
The ClinicalTrials.gov registry entry for NCT01300052 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AN2728 ointment, 2% is the first listed.
NCT01300052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01300052 about?
NCT01300052 is a clinical study titled "AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis". The purpose of this study is to determine whether AN2728 topical ointment is a safe and effective treatment for mild-to-moderate plaque-type psoriasis.
What is the current status of trial NCT01300052?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 2011-01-26. Estimated completion is 2011-06-06.
What interventions are being tested in trial NCT01300052?
The interventions under investigation include: AN2728 ointment, 2% (DRUG), Ointment Vehicle (DRUG).
Who is sponsoring clinical trial NCT01300052?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.